1. Extra-hepatic tumor recurrence after directly-acting-antiviral (DAA) therapy in HCV patients. (February 2019) Authors: Torres, M.C. Plaz; Lamonaca, L.; Nalda, A. Lleo De; Ceriani, R.; Rimassa, L.; Personeni, N.; Colombo, M.; Aghemo, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High Incidence of sepsis caused by MDR bacteria in patients undergoing Percutaneous biliary drainage for the treatment of biliary obstruction. (March 2023) Authors: De Nicola, S.; Cento, V.; Fortunato, M.; Masetti, C.; Colapietro, F.; Pugliese, N.; Ceriani, R.; Bianchi, I.; Pedicini, V.; Lanza, E.; Torzilli, G.; Lleo, A.; Aghemo, A. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High prevalence of multiple drug resistant bacterial infections in patients with pyogenic liver abscesses following loco regional therapy for liver cancer. (March 2021) Authors: Colapietro, F.; Masetti, C.; Pugliese, N.; Bianchi, I.; Poretti, D.; Pedicini, V.; Lleo, A.; Ceriani, R.; Aghemo, A. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low glomerular filtration rate is a risk factor for ribavirin‐associated anaemia in old patients with chronic hepatitis C. Issue 4 (22nd October 2012) Authors: Borroni, G.; Cazzaniga, M.; Andreoletti, M.; Ceriani, R.; Guerzoni, P.; Omazzi, B.; Pich, M. G. L.; Prada, A.; Spinzi, G.; Terreni, N.; Salerno, F. Journal: Journal of viral hepatitis Issue: Volume 20:Issue 4(2013) Page Start: e90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Myosteatosis is not associated with complications or survival in HCC patients undergoing transarterial embolization. (March 2023) Authors: Masetti, C.; Pugliese, N.; Lofino, L.; Colapietro, F.; Ceriani, R.; Lleo, A.; Poretti, D.; Pedicini, V.; De Nicola, S.; Torzilli, G.; Rimassa, L.; Aghemo, A.; Lanza, E. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. No impact of the 2020 COVID-19 lockdown on hospitalization rates for alcoholic liver disease in a large tertiary hospital in Milan. (March 2021) Authors: Masetti, C.; Colapietro, F.; Pugliese, N.; De Fazio, F.; Voza, A.; Bianchi, I; Ceriani, R.; Lleo, A.; Aghemo, A. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.12.5 MYOSTEATOSIS IS NOT ASSOCIATED WITH COMPLICATIONS OR SURVIVAL IN HCC PATIENTS UNDERGOING TRANS ARTERIAL EMBOLIZATION. (March 2023) Authors: De Marco, A.; Masetti, C.; Pugliese, N.; Lofino, L.; Colapietro, F.; Ceriani, R.; Lleo, A.; Poretti, D.; Pedicini, V.; De Nicola, S.; Torzilli, G.; Rimassa, L.; Aghemo, A.; Lanza, E. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications. (February 2020) Authors: Masetti, C.; Pugliese, N.; Messana, G.; Ceriani, R.; Poretti, D.; LLeo, A.; Lanza, E.; Colombo, M.; Personeni, N.; Pedicini, V.; Torzilli, G.; Aghemo, A. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗